← Back to headlines
Teva Submits NDA for Ecopipam to Treat Pediatric Tourette's
Teva Pharmaceuticals has submitted a New Drug Application (NDA) for ecopipam, a medication intended for the treatment of Tourette's syndrome in pediatric patients.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
